Amgen subsidiary deCODE Genetics has identified new risk factors and genes associated with clonal hematopoiesis, a precursor state to blood cancer. In the results of a study published Nov. 6 in Nature ...
REYKJAVIK, Iceland, Jan. 29, 2024 /PRNewswire/ -- Scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from Iceland, Denmark, and the USA published a study today in Nature ...
REYKJAVIK, Iceland, July 24, 2024 /PRNewswire/ -- A new study by scientists at deCODE Genetics, subsidiary of Amgen, shows that sequence variants drive the correlation between DNA methylation and gene ...
REYKJAVIK, Islandia, 22 de enero de 2025 /PRNewswire/ -- Los científicos de deCODE genetics/Amgen han elaborado un mapa completo de cómo se mezcla el ADN humano a medida que se transmite durante la ...
Scientists at deCODE genetics, a subsidiary of AMGEN, have discovered rare sequence variants, predicted to cause a loss of function of ITSN1, that are associated with a high risk of Parkinson‘s ...
Scientists at deCODE genetics/Amgen have constructed a complete map of how human DNA is mixed as it is passed down during reproduction. The map marks a major step in the understanding of genetic ...
Amgen has agreed to acquire deCode Genetics for $415 million. Based in Reykjavik, Iceland, deCode deciphers the links between genetics and human diseases largely by relying on Iceland’s exceptionally ...
Reykjavik, Iceland, 2-dec-2021. In a study published today in Nature Genetics, scientists at deCODE genetics , a subsidiary of the pharmaceutical company Amgen, demonstrate how measuring the levels of ...
A new computational machine learning method developed by computational biologists can help researchers discover spatial patterns of gene expression in diseased tissue. In disease research, it's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback